This trial is !
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Adult Acute Lymphoblastic Leukemia, Adult Lymphoblastic Lymphoma or Philadelphia Chromosome Positive
and you are
over 18
years old
2
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

This phase II trial studies how well etoposide, prednisone, vincristine sulfate, cyclophosphamide, and doxorubicin (DA-EPOCH) works in treating patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Drugs used in chemotherapy, such as etoposide, prednisone, vincristine sulfate, cyclophosphamide, and doxorubicin, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.

Provided treatments

  • Drug: Cyclophosphamide
  • Drug: Dasatinib
  • Drug: Doxorubicin
  • Drug: Etoposide
  • Drug: Imatinib Mesylate
  • Other: Laboratory Biomarker Analysis
  • Drug: Prednisone
  • Biological: Rituximab
  • Drug: Vincristine Sulfate
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03023046. The sponsor of the trial is University of Washington and it is looking for 28 volunteers for the current phase.
Official trial title:
A Phase II Study of Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) as Front-Line Therapy for Adults With Acute Lymphoblastic Leukemia/Lymphoma